TH1 predominance is associated with improved survival in pediatric medulloblastoma patients

Cancer Immunology, Immunotherapy

Volumn 60, Issue 5, 2011, Pages 693-703

  Wiegering, Verena ^a   Eyrich, Matthias ^a   Rutkowski, Stefan ^a,b   Wölfl, Matthias ^a   Schlegel, Paul G ^a   Winkler, Beate ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

High dose chemotherapy; IFN and TNF ; Pediatric medulloblastoma; Prognostic factors; T cell reconstitution; TH1 predominance

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; TEMOZOLOMIDE; THIOTEPA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; LEUKAPHERESIS; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PERIPHERAL BLOOD STEM CELL; PINEOBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; T LYMPHOCYTE; TH1 CELL;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; MALE; MEDULLOBLASTOMA; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T-LYMPHOCYTES; TH1 CELLS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955544668     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-0981-y     Document Type: Article

References (58)

1. JG Gurney E van Wijngaarden 1999 Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: review and comment Neuro Oncol 1 3 212 220 11550314 1:STN:280:DC%2BD3MrgtFCrtQ%3D%3D
2. BR Rood TJ Macdonald RJ Packer 2004 Current treatment of medulloblastoma: recent advances and future challenges Semin Oncol 31 5 666 675 15497120 (Pubitemid 39389018)
3. S Rutkowski U Bode F Deinlein H Ottensmeier M Warmuth-Metz N Soerensen N Graf A Emser T Pietsch JE Wolff RD Kortmann J Kuehl 2005 Treatment of early childhood medulloblastoma by postoperative chemotherapy alone N Engl J Med 352 10 978 986 10.1056/NEJMoa042176 15758008 1:CAS:528:DC%2BD2MXit1WksLs%3D (Pubitemid 40349500)
4. Ottensmeier H, Frahsek S, Faldum A, Rutkowski S (2010) Longterm neuropsychological follow up of young children with medulloblastoma and ependymoma treated in the trials HIT-SKK 87/92 and HIT2000. Neuro Oncol 12 (6):ii13
5. SL Palmer O Goloubeva WE Reddick JO Glass A Gajjar L Kun TE Merchant RK Mulhern 2001 Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis J Clin Oncol 19 8 2302 2308 11304784 1:STN:280:DC%2BD3M3mtFOgsw%3D%3D (Pubitemid 32366983)
6. S Rutkowski 2006 Current treatment approaches to early childhood medulloblastoma Expert Rev Neurother 6 8 1211 1221 10.1586/14737175.6.8.1211 16893348 (Pubitemid 44231978)
7. KE Warren RJ Packer 2004 Current approaches to CNS tumors in infants and very young children Expert Rev Neurother 4 4 681 690 10.1586/14737175.4.4.681 15853587 (Pubitemid 38890596)
8. J Grill C Sainte-Rose A Jouvet JC Gentet O Lejars D Frappaz F Doz X Rialland F Pichon AI Bertozzi P Chastagner D Couanet JL Habrand MA Raquin MC Le Deley C Kalifa 2005 Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children Lancet Oncol 6 8 573 580 10.1016/S1470-2045(05)70252-7 16054568 1:CAS:528:DC%2BD2MXmvVWmtrw%3D (Pubitemid 41051935)
9. JE Wolff JL Finlay 2004 High-dose chemotherapy in childhood brain tumors Onkologie 27 3 239 245 10.1159/000077973 15249712 1:STN:280: DC%2BD2czks1Oiuw%3D%3D (Pubitemid 39279332)
10. IJ Dunkel JL Finlay 2002 High-dose chemotherapy with autologous stem cell rescue for brain tumors Crit Rev Oncol Hematol 41 2 197 204 11856595 (Pubitemid 34150130)
11. CL Mackall TA Fleisher MR Brown IT Magrath AT Shad ME Horowitz LH Wexler MA Adde LL McClure RE Gress 1994 Lymphocyte depletion during treatment with intensive chemotherapy for cancer Blood 84 7 2221 2228 7919339 1:STN:280:DyaK2M%2Fgt12gsA%3D%3D (Pubitemid 24296382)
12. A Perez-Martinez V Quintero MG Vicent J Sevilla MA Diaz L Madero 2004 High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors J Neurooncol 67 1-2 101 106 15072454 (Pubitemid 38418255)
13. F Berthold J Boos S Burdach R Erttmann G Henze J Hermann T Klingebiel B Kremens FH Schilling M Schrappe T Simon B Hero 2005 Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial Lancet Oncol 6 9 649 658 10.1016/S1470-2045(05)70291-6 16129365 1:CAS:528:DC%2BD2MXpslynsrw%3D (Pubitemid 41222755)
14. E Leo PG Schlegel A Lindemann 1997 Chemotherapeutic induction of long-term remission in metastatic medulloblastoma J Neurooncol 32 2 149 154 9120544 1:STN:280:DyaK2s3gt1entQ%3D%3D (Pubitemid 27077983)
15. A Gajjar M Chintagumpala D Ashley S Kellie LE Kun TE Merchant S Woo G Wheeler V Ahern MJ Krasin M Fouladi A Broniscer R Krance GA Hale CF Stewart R Dauser RA Sanford C Fuller C Lau JM Boyett D Wallace RJ Gilbertson 2006 Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial Lancet Oncol 7 10 813 820 10.1016/S1470-2045(06)70867-1 17012043 (Pubitemid 44464063)
16. Fleischhack G, Popping K, Hasan C, Utsch B, Juttner J, Bode U (1998) High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study. Klin Padiatr 210(4):248-255. doi: 10.1055/s-2008-1043887 (Pubitemid 28361248)
17. PM Zeltzer JM Boyett JL Finlay AL Albright LB Rorke JM Milstein JC Allen KR Stevens P Stanley H Li JH Wisoff JR Geyer P McGuire-Cullen JA Stehbens SB Shurin RJ Packer 1999 Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study J Clin Oncol 17 3 832 845 10071274 1:CAS:528:DyaK1MXhvFGgur0%3D (Pubitemid 29109313)
18. IJ Dunkel JM Boyett A Yates M Rosenblum JH Garvin Jr BC Bostrom S Goldman LS Sender SL Gardner H Li JC Allen JL Finlay 1998 High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group J Clin Oncol 16 1 222 228 9440746 1:CAS:528:DyaK1cXmsVCqtg%3D%3D (Pubitemid 28041602)
19. N Meister T Shalaby AO von Bueren P Rivera R Patti C Oehler M Pruschy MA Grotzer 2007 Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy Eur J Cancer 43 12 1833 1841 10.1016/j.ejca.2007.05.028 17627812 1:CAS:528:DC%2BD2sXovFGnt7c%3D (Pubitemid 47238252)
20. MA Grotzer A Eggert TJ Zuzak AJ Janss S Marwaha BR Wiewrodt N Ikegaki GM Brodeur PC Phillips 2000 Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression Oncogene 19 40 4604 4610 10.1038/sj.onc.1203816 11030149 1:CAS:528: DC%2BD3cXnsFensLo%3D
21. TJ Zuzak DF Steinhoff LN Sutton PC Phillips A Eggert MA Grotzer 2002 Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma Eur J Cancer 38 1 83 91 11750844 1:CAS:528:DC%2BD3MXpt1ait7g%3D (Pubitemid 34031830)
22. JC Reed 1999 Caspases and cytokines: roles in inflammation and autoimmunity Adv Immunol 73 265 299 10399008 1:CAS:528:DC%2BD3cXht1alsrs%3D (Pubitemid 29300431)
23. S Fulda KM Debatin 2006 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8 Oncogene 25 37 5125 5133 10.1038/sj.onc.1209518 16607283 1:CAS:528:DC%2BD28XosVOmtLo%3D (Pubitemid 44285981)
24. EA Bach M Aguet RD Schreiber 1997 The IFN gamma receptor: a paradigm for cytokine receptor signaling Annu Rev Immunol 15 563 591 10.1146/annurev.immunol. 15.1.563 9143700 1:CAS:528:DyaK2sXisVCmt7c%3D (Pubitemid 27169292)
25. U Boehm T Klamp M Groot JC Howard 1997 Cellular responses to interferon-gamma Annu Rev Immunol 15 749 795 10.1146/annurev.immunol.15.1.749 9143706 1:CAS:528:DyaK2sXisVGju7o%3D (Pubitemid 27169298)
26. H Ikeda LJ Old RD Schreiber 2002 The roles of IFN gamma in protection against tumor development and cancer immunoediting Cytokine Growth Factor Rev 13 2 95 109 11900986 1:CAS:528:DC%2BD38XitFWhsrs%3D (Pubitemid 34229385)
27. S Pfister M Remke A Benner F Mendrzyk G Toedt J Felsberg A Wittmann F Devens NU Gerber S Joos A Kulozik G Reifenberger S Rutkowski OD Wiestler B Radlwimmer W Scheurlen P Lichter A Korshunov 2009 Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci J Clin Oncol 27 10 1627 1636 10.1200/JCO.2008.17.9432 19255330
28. Packer RJ (2005) Medulloblastoma. J Neurosurg 103(4 Suppl):299-300. doi: 10.3171/ped.2005.103.4.0299 (discussion 300-291)
29. S Rutkowski A von Bueren K von Hoff W Hartmann T Shalaby F Deinlein M Warmuth-Metz N Soerensen A Emser U Bode U Mittler C Urban M Benesch RD Kortmann PG Schlegel J Kuehl T Pietsch M Grotzer 2007 Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91 Clin Cancer Res 13 9 2651 2657 10.1158/1078-0432.CCR-06-1779 17473196 1:CAS:528:DC%2BD2sXkslOhtbg%3D (Pubitemid 46788032)
30. Shalaby T, von Bueren AO, Hurlimann ML, Fiaschetti G, Castelletti D, Masayuki T, Nagasawa K, Arcaro A, Jelesarov I, Shin-ya K, Grotzer M (2010) Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Mol Cancer Ther 9(1):167-179. doi: 10.1158/1535-7163.MCT-09-0586
31. M Eyrich V Wiegering A Lim A Schrauder B Winkler PG Schlegel 2009 Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients Br J Haematol 147 3 360 370 10.1111/j.1365-2141.2009.07862.x 19694715 1:CAS:528:DC%2BD1MXhsVSnsb%2FJ
32. B Mascher P Schlenke M Seyfarth 1999 Expression and kinetics of cytokines determined by intracellular staining using flow cytometry J Immunol Methods 223 1 115 121 10037239 1:CAS:528:DyaK1MXksFOjtg%3D%3D (Pubitemid 29096243)
33. M Eyrich T Croner C Leiler P Lang P Bader T Klingebiel D Niethammer PG Schlegel 2002 Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors Blood 100 5 1915 1918 10.1182/blood-2001-11-0005 12176918 1:CAS:528:DC%2BD38Xmslyhur4%3D (Pubitemid 34925175)
34. M Eyrich G Wollny N Tzaribaschev K Dietz D Brugger P Bader P Lang K Schilbach B Winkler D Niethammer PG Schlegel 2005 Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children Biol Blood Marrow Transplant 11 3 194 205 10.1016/j.bbmt.2004.12.001 15744238 (Pubitemid 40287918)
35. KW Sung KH Yoo EJ Cho HH Koo H Lim do HJ Shin SD Ahn YS Ra ES Choi TT Ghim 2007 High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor Pediatr Blood Cancer 48 4 408 415 10.1002/pbc.21064 17066462 (Pubitemid 46340106)
36. H Guo Z Qiao L Zhu H Wang L Su Y Lu Y Cui B Jiang Q Zhu L Xu 2004 Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation Am J Hematol 75 2 78 83 10.1002/ajh.10443 14755372 1:CAS:528:DC%2BD2cXitFSlur4%3D (Pubitemid 38160595)
37. DK Mitra HP Singh M Singh A Alwadi V Kochupillai V Raina L Kumar NK Mehra 2002 Reconstitution of naive T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer Transplantation 73 8 1336 1339 11981431 1:CAS:528:DC%2BD38Xkt1Cqt7Y%3D (Pubitemid 34454285)
38. CL Mackall D Stein TA Fleisher MR Brown FT Hakim CV Bare SF Leitman EJ Read CS Carter LH Wexler RE Gress 2000 Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults Blood 96 2 754 762 10887145 1:CAS:528:DC%2BD3cXltVGgsrY%3D (Pubitemid 30463402)
39. T Guillaume DB Rubinstein M Symann 1998 Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation Blood 92 5 1471 1490 9716573 1:CAS:528:DyaK1cXls1Siur0%3D (Pubitemid 28406849)
40. S Hoepfner PR Haut M O'Gorman M Kletzel 2003 Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: a single institution experience Bone Marrow Transplant 31 4 285 290 10.1038/sj.bmt.1703831 12621464 1:STN:280:DC%2BD3s7gslynsw%3D%3D (Pubitemid 36336232)
41. K Kalwak E Gorczynska J Toporski D Turkiewicz M Slociak M Ussowicz E Latos-Grazynska M Krol J Boguslawska-Jaworska A Chybicka 2002 Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery Br J Haematol 118 1 74 89 12100130 1:CAS:528:DC%2BD38XmtlWru7Y%3D (Pubitemid 34779519)
42. P Reimer V Kunzmann M Wilhelm B Weissbrich D Kraemer H Berghammer F Weissinger 2003 Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT) Ann Hematol 82 5 263 270 10.1007/s00277-003-0630-4 12739062 1:STN:280:DC%2BD3s3pslKhtg%3D%3D (Pubitemid 36701419)
43. V Bronte S Mocellin 2009 Suppressive influences in the immune response to cancer J Immunother 32 1 1 11 10.1097/CJI.0b013e3181837276 19307988
44. J Chipeta Y Komada XL Zhang T Deguchi K Sugiyama E Azuma M Sakurai 1998 CD4 + and CD8 + cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age Cell Immunol 183 2 149 156 10.1006/cimm.1998.1244 9606999 1:CAS:528: DyaK1cXjt1Kquro%3D (Pubitemid 28222271)
45. F Hoffmann MH Albert S Arenz C Bidlingmaier N Berkowicz S Sedlaczek H Till I Pawlita ED Renner M Weiss BH Belohradsky 2005 Intracellular T-cell cytokine levels are age-dependent in healthy children and adults Eur Cytokine Netw 16 4 283 288 16464742 1:CAS:528:DC%2BD28XhvFKktL0%3D (Pubitemid 350056543)
46. V Wiegering M Eyrich C Wunder H Gunther PG Schlegel B Winkler 2009 Age-related changes in intracellular cytokine expression in healthy children Eur Cytokine Netw 20 2 75 80 10.1684/ecn.2009.0149 19541593 1:CAS:528: DC%2BD1MXhtVWrurbL
47. PP Lee D Zeng AE McCaulay YF Chen C Geiler DT Umetsu NJ Chao 1997 T helper 2-dominant antilymphoma immune response is associated with fatal outcome Blood 90 4 1611 1617 9269780 1:CAS:528:DyaK2sXltlOrtLc%3D (Pubitemid 27355434)
48. K Dredge JB Marriott SM Todryk AG Dalgleish 2002 Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy Cancer Immunol Immunother 51 10 521 531 10.1007/s00262-002-0309-z 12384803 1:CAS:528: DC%2BD38XnvV2ltro%3D (Pubitemid 35232001)
49. MA Santana Y Rosenstein 2003 What it takes to become an effector T cell: the process, the cells involved, and the mechanisms J Cell Physiol 195 3 392 401 10.1002/jcp.10258 12704648 1:CAS:528:DC%2BD3sXjs1yhs7g%3D (Pubitemid 36529867)
50. B Popko KD Baerwald 1999 Oligodendroglial response to the immune cytokine interferon gamma Neurochem Res 24 2 331 338 9972883 1:CAS:528: DyaK1MXmt1Ortg%3D%3D (Pubitemid 29067978)
51. D Sredni-Kenigsbuch 2002 TH1/TH2 cytokines in the central nervous system Int J Neurosci 112 6 665 703 12325311 (Pubitemid 34706624)
52. JG Corbin D Kelly EM Rath KD Baerwald K Suzuki B Popko 1996 Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development Mol Cell Neurosci 7 5 354 370 10.1006/mcne.1996.0026 8812062 1:CAS:528:DyaK28XksFSqurc%3D (Pubitemid 26250825)
53. FM LaFerla MC Sugarman TE Lane MA Leissring 2000 Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma J Mol Neurosci 15 1 45 59 10.1385/JMN:15:1:45 11211236 1:CAS:528:DC%2BD3MXns1Clsg%3D%3D (Pubitemid 32104604)
54. W Lin A Kemper KD McCarthy P Pytel JP Wang IL Campbell MF Utset B Popko 2004 Interferon-gamma induced medulloblastoma in the developing cerebellum J Neurosci 24 45 10074 10083 10.1523/JNEUROSCI.2604-04.2004 15537876 1:CAS:528:DC%2BD2cXhtVeqtLfP (Pubitemid 39492031)
55. C Pingoud-Meier D Lang AJ Janss LB Rorke PC Phillips T Shalaby MA Grotzer 2003 Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma Clin Cancer Res 9 17 6401 6409 14695141 1:CAS:528:DC%2BD3sXhtVSqur3K (Pubitemid 38031826)
56. T Cloppenborg M Stanulla M Zimmermann M Schrappe K Welte C Klein 2005 Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups Leukemia 19 1 44 48 10.1038/sj.leu.2403553 15496974 1:CAS:528:DC%2BD2cXhtVKnsb%2FE (Pubitemid 40090075)
57. L Dai A Gast A Horska M Schrappe CR Bartram K Hemminki R Kumar JL Bermejo 2009 A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes Pediatr Blood Cancer 52 7 819 823 10.1002/pbc.21971 19229971
58. K Seidemann M Zimmermann M Book U Meyer B Burkhardt K Welte A Reiter M Stanulla 2005 Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95 J Clin Oncol 23 33 8414 8421 10.1200/JCO.2005.01.2179 16293872 1:CAS:528:DC%2BD2MXhtlWhtrbM